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ABSTRACT In previous in vivo studies, amyloid ﬁbers formed from a peptide ubiquitous in human seminal ﬂuid (semen-derived
enhancer of viral infection (SEVI)) were found to dramatically enhance the infectivity of the HIV virus (3–5 orders of magnitude by
some measures). To complement those studies, we performed in vitro assays of PAP248-286, the most active precursor to SEVI,
and other polycationic polymers to investigate the physical mechanisms by which the PAP248-286 promotes the interaction with
lipid bilayers. At acidic (but not at neutral) pH, freshly dissolved PAP248-286 catalyzes the formation of large lipid ﬂocculates in
a variety of membrane compositions, which may be linked to the promotion of convective transport in the vaginal environment
rather than transport by a random Brownian motion. Furthermore, PAP248-286 is itself fusiogenic and weakens the integrity of the
membrane in such a way that may promote fusion by the HIV gp41 protein. An a-helical conformation of PAP248-286, lying parallel
to the membrane surface, is implicated in promoting bridging interactions between membranes by the screening of the electro-
static repulsion that occurs when two membranes are brought into close contact. This suggests that nonspeciﬁc binding of mono-
meric or small oligomeric forms of SEVI in a helical conformation to lipid membranes may be an additional mechanism by which
SEVI enhances the infectivity of the HIV virus.INTRODUCTION
A puzzling discrepancy in AIDS research is the low in vitro
activity of the virus compared to the explosive growth of the
AIDS pandemic. It is estimated that AIDS has killed 25
million people since it was first recognized in 1981, making
it one of the most destructive epidemics in human history.
Yet the HIV virus is a surprisingly weak pathogen in vitro,
with only a small percentage (0.1–.001%) of the virus parti-
cles able to replicate in vitro (1,2). Given the high rate of
mutation of the HIV virus, it might seem reasonable to
conclude that large numbers of structurally defective virus
particles are produced, and only a small percentage of virus
particles that are able to complete the steps of the virus life
cycle are generated. Recent studies have shown that most
virus particles are functional and, given the right opportu-
nity, will infect their target cells (3). However, in contrast
to the in vivo situation, in vitro conditions are such that
most virus particles are never given the correct opportunity
to attach and fuse with the target cell before the virus particle
is degraded.
What is this critical difference between the in vivo and
in vitro situations? HIV has an incredible ability to evolve
quickly due to the high error rate of the viral reverse transcrip-
tase. Given the HIV virus’s ability to mutate rapidly, it also
seems natural for the virus to exploit any available factors in
the host environment that could be advantageous for infec-
tion. Because seminal fluid is ubiquitous during the sexual
transmission of HIV, it is a likely source for cofactors that
either inhibit or enhance the infectivity of the HIV virus
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0006-3495/09/11/2474/10 $2.00(4–6). Despite the presence of seminal fluid in the vast
majority of HIV infections, surprisingly little is known about
the effects of semen on HIV infectivity (7–9). Although
seminal fluid has been shown to enhance the binding of
HIV virions to epithelial cells (9), the active component in
enhancing the infectivity of HIV has only recently been iden-
tified. Fragments of prostatic acid phosphatase (PAP), a highly
abundant protein found in human semen, act as a very
dramatic enhancer of HIV infectivity. Fragments of PAP,
named semen-derived enhancer of viral infection (SEVI;
Fig. 1), were shown to strongly promote HIV virus-cell
attachment and fusion in multiple viral and host cell geno-
types at physiological concentrations (4). Most surprisingly,
and most importantly, the SEVI peptide was found to drasti-
cally reduce the number of virus particles needed to establish
infection under the low viral load conditions resembling
sexual transmission. A truly remarkable enhancement of
4–5 orders of magnitude occurred when limiting amounts of
virus were used. By comparison, most known endogenous
enhancers had a much more modest 2–3-fold effect on the
degree of HIV infectivity. In contrast to the large (and unreal-
istic) viral loads needed to infect cells in vitro, only 1–3 virus
particles were necessary to establish a persistent infection in
dendritic cells in the presence of SEVI (4). Notably, these
assays detected spreading HIV-1 infection, implying that
the detected virions were replication competent.
The mechanism by which SEVI enhances this remarkable
enhancement of HIV infection is largely unknown. SEVI
apparently has little effect on the transcription of viral
RNA, as the reverse transcriptase inhibitor Efavirenz blocks
viral gene expression in the presence of SEVI (4). However,
SEVI drastically enhances viral binding and entry into cells,
doi: 10.1016/j.bpj.2009.08.034
SEVI Promotes Lipid Fusion 2475enhancing HIV-1 viral fusion and subsequent gene expres-
sion ~10-fold (4). Furthermore, some degree of aggregation
of the peptide is necessary for activity, since freshly prepared,
monomeric solutions of SEVI are ineffective at promoting
viral infectivity, and the enhancement of HIV infectivity
increases with time as SEVI is incubated in solution. It has
been established that SEVI is an amyloidogenic peptide,
and that amyloid fibers of the peptide are more effective
than the monomeric peptide in promoting HIV cell binding
and membrane fusion (4). This is in agreement with previous
studies that showed amoremodest enhancement of infectivity
of enveloped viruses by other amyloidogenic proteins, such as
the Ab peptide (10). However, the form of SEVI responsible
was not clearly identified, as the rise in infectivity induced by
SEVI preceded the formation of amyloid fibers (4).
Naturally occurring SEVI (the most active form of which is
PAP248-286) has a very large effect on the infectivity of the HIV
virus. The physical mechanism bywhich it enhances the infec-
tivity of HIV virus is not understood, but it has been hypothe-
sized that amyloid fibers of SEVI physically capture entering
virus particles and promote their interaction with the target
cell membrane without bypassing the requirement for the
appropriate cell receptor (4). The form of SEVI that is most
active in this respect has not been identified, and the available
data are somewhat inconclusive as regards the requirement
for amyloid formation for enhancement of HIV infection.
PAP248-286 isolated in the monomeric form by size exclusion
chromatography is ineffective at promoting HIV infection,
and centrifugationofPAP248-286 has shown that activity resides
in the high-molecular-weight pellet rather than in the low-
molecular-weight supernatant (4). However, time-dependent
assays have shown that the infection-promoting activity of
PAP248-286 begins to increase well before amyloid formation
occurs, asmeasuredbyb-sheet formationbycircular dichroism
(CD), Thioflavin T binding, or Congo red staining (4). In
addition, the enhancement of infection shows up immediately
when seminal fluid is spiked with freshly dissolved PAP248-286
at pH 8.8, and within 30 min at pH 4.2 (4). Mu¨nch et al. (4)
noted that the polycationic polymer Polybrene also promoted
HIV infection (to a lesser degree than SEVI), a phenomenon
that has also been noted for other retroviruses (11–14). The
time-dependent results therefore suggest that an aggregated,
but nonamyloid, form of PAP248-286 can be as effective or
even more effective than the fibrillar form of PAP248-286 (4).
These experiments were performed on in vivo systems, whose
complexity complicates attempts to determine the physical
basis for the interaction of SEVI with membranes. The use of
simpler model membranes allows the dissection of physico-
FIGURE 1 Sequences of PAP248-286 and IAPP. (Top row) Sequence of
PAP248-286. (Bottom row) Sequence of the control amyloidogenic peptide
human IAPP. The C-terminus is amidated and a disulfide bond exists
between Cys2 and Cys7.chemical effects caused by the peptide, such as increased fusio-
genicity and charge neutralization of the cellular membrane,
from the effects on more complex properties such as cell
viability and motility. The preliminary in vitro results shown
here suggest that, under acidic conditions, freshly dissolved
nonfibrillar PAP248-286 appears to act similarly to other polyca-
tionic polymers, such as polybrene and polylysine, that act as
general promoters of viral fusion (11–17).
MATERIALS AND METHODS
Lipid compositions of host and viral type membranes can be found in Aloia
et al. (18) and in the Supporting Material. Details of vesicle preparation and
CD spectroscopy can be found in Brender et al. (19) and in the Supporting
Material. Further details about the materials and methods used in this study
can be found in the Supporting Material.
RESULTS
Freshly dissolved PAP248-286 promotes the
aggregation of lipid vesicles
SEVI peptides have been proposed to increase the infectivity
of HIV by increasing the attachment of virus particles to the
cell membrane through charge neutralization. To compare
the efficiency of PAP248-286 with that of other cationic poly-
mers, we performed turbidity assays for the aggregation of
lipid vesicles induced by PAP248-286, polybrene, and the amy-
loidogenic peptide human islet amyloid polypeptide (IAPP)
(Fig. 2). The assays were performed at two different lipid
concentrations to test the effects of the peptide/lipid ratio on
vesicle aggregation. At this pH, none of the compounds
induced substantial vesicle aggregation at a lipid concentra-
tion of 200 mM or 1000 mM. Polybrene, a highly charged
cationic polymer commonly used to increase the efficiency
of gene transfection, caused the most aggregation of the com-
pounds tested (Fig. 2 A). Freshly dissolved human-IAPP, an
amyloidogenic peptide with a charge ofþ3 at pH 7.3, caused
slightly less aggregation. Significantly, freshly dissolved
PAP248-286 did not induce any aggregation at this pH, in agree-
ment with the finding that freshly dissolved PAP248-286 does
not increaseHIV infectivity and presumably does not increase
the attachment of virus particles to the cell membrane.
The ability of SEVI to increase HIV infectivity has been
linked to its cationic nature, since mutants in which the
charged residues in PAP248-286 are mutated to alanine form
amyloid fibers but are not able to increase HIV infection
rates (20). To check the influence of electrostatics on
PAP248-286 binding, we used an alternate lipid composition
of 100% 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphatidyl-
glycerol (POPG; Fig. 2 B). The amount of lipid aggregation
in this model membrane increased but was still less than has
been reported for other amyloidogenic peptides (21).
The vaginal environment is typically acidic (near pH 4),
and polycation-induced membrane aggregation and mem-
brane fusion increase substantially near this pH as the pH
approaches the pKa of the phosphatidylglycerol orBiophysical Journal 97(9) 2474–2483
2476 Brender et al.phosphatidylserineheadgroup (22–24). In addition, PAP248-286
also has two His residues that are likely to be charged at
pH 4 but not at pH 7.3, resulting in a higher electrostatic
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FIGURE 2 Lipid aggregation of liposomes detected by changes in
turbidity at pH 7.3 (A) in the presence of POPC/POPG (7:3 ratio) vesicles
and (B) POPG vesicles. Reported values are the changes in the absorbance
at 350 nm relative to the control immediately after addition of the peptide or
polymer and vigorous mixing. Two different lipid concentrations (200 mM
and 1000 mM) were used as indicated.Biophysical Journal 97(9) 2474–2483interaction with the membrane at pH 4. In contrast to the
neutral pH condition, PAP248-286 caused appreciable lipid
aggregation at acidic pH in 7:3 1-palmitoyl-2-oleoyl-sn-
glycero-3-phosphatidylcholine (POPC)/POPG liposomes
(Fig. 3 A). Furthermore, the lipid aggregates produced are
considerably larger than those produced at neutral pH and
could be visibly detected sedimenting to the bottom of the
cuvette, even under the influence of shaking or stirring
(Fig. 3, D and E). Of interest, the decrease in pH had the
opposite effect on human-IAPP, which caused more lipid
aggregation than PAP248-286 at neutral pH but did not cause
any detectible lipid aggregation at pH 4. Similar results were
obtained with membranes resembling the viral envelope
(Fig. 3 B) and host cell (Fig. 3 C), albeit with a lesser degree
of aggregation, most likely due to the decreased amount of
anionic lipids or increased cholesterol content in these
membranes.
Freshly dissolved PAP248-286 promotes the mixing
of lipid molecules between membranes in
a manner suggestive of membrane fusion
In addition to promoting the binding of liposomes to each
other, PAP248-286 promotes the interchange of the membranes
of both vesicles, as measured by a fluorescence probe dilution
assay. Small unilamellar vesicles (SUVs) doubly labeled with
rhodamine and NBD-labeled glycerophosphocholine probes
(1% each) were mixedwith unlabeled vesicles in the presence
of the indicated concentrations of peptide. Fusion of the
labeled vesicles with the unlabeled ones results in an
increased average distance between probes and a decreased
fluorescence resonance energy transfer (FRET) efficiency.
Polylysine, polybrene, and PAP248-286 all promoted the fusion
of POPC/POPG SUVs in the absence of calcium (Fig. 4). In0
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FIGURE 3 Lipid aggregation of lipo-
somes of varying composition detected
by changes in turbidity at pH 4: (A)
7:3 POPC/POPG, (B) viral membrane
composition, and (C) host cell mem-
brane composition. Reported values
are the changes in the absorbance at
350 nm relative to the control immedi-
ately after addition of the peptide or
polymer and vigorous mixing. (D)
A photograph of the sample containing
100 nm 7:3 POPC/POPG liposomes
at 500 mM concentration before the
addition of 17.5 mM PAP248-286. (E)
A photograph of the same sample
10 min after the addition of 17.5 mM
PAP248-286.
SEVI Promotes Lipid Fusion 2477contrast to vesicle aggregation, lipid mixing induced by low
concentrations (<10 mM) of PAP248-286 appears to be nearly
as effective at neutral pH as at acidic pH. At higher concentra-
tions (>12.5 mM) PAP248-286 becomes as effective as polyly-
sine at promoting the fusion of SUVs.
PAP248-286 induces negative curvature
in the membrane
The process of vesicle fusion is marked by the formation of
a highly curved intermediate that is energetically unfavor-
able (25). Peptides that interact with the membrane in
such a way as to reduce the physical stress imposed on
the membrane by the formation of this highly curved inter-
mediate can be expected to enhance fusion (26,27). The
stabilization of membrane curvature by PAP248-286 can be
conveniently followed by recording the shift in the phase
transition temperature from the flat liquid crystalline (La)
phase to the highly curved inverted hexagonal phase (HII)
in which the lipid molecules are arranged cylindrically
with the polar headgroups facing inward (26–30). Peptides
that either stabilize negative (convex) membrane curvature
or increase the bending elasticity of the membrane will favor
the formation of the HII phase, and will accordingly decrease
the associated phase transition temperature (TH) (31–34).
DiPoPE has a TH of 47.8
C under these conditions in the
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FIGURE 4 Membrane fusion induced at (A) pH 7.3 and (B) pH 4 by
PAP248-286 in 7:3 POPC/POPG vesicles as measured by a FRET-based lipid
mixing assay. Samples were normalized to 100% lipid mixing using the
FRET efficiency in the presence of 1% Triton-X.absence of PAP248-286. The incorporation of PAP248-286
into DiPoPE multilamellar vesicles reduced TH (Fig. 5), indi-
cating PAP248-286 facilitates the formation of the highly
curved HII phase. The reduction of TH with the incorporation
of PAP248-286 occurs as a two-step (or multiple-step) process.
The incorporation of a very small percentage (0.00625mol%)
of PAP248-286 into the DiPoPE vesicles led to a 0.9
C
decrease in TH, whereas larger percentages (0.25 and
0.4%) were required for further decreases in TH. The reason
for the multistage nature of the decrease in TH is unclear at
present.
Freshly dissolved PAP248-286 induces membrane
disruption
Many amyloid peptides are disruptive to membranes, and
damage to the integrity of the cellular membrane is believed
to be one of the main causes of amyloid-related pathologies.
To see whether the PAP248-286 peptide also possesses this
prominent feature of amyloid peptides, we performed dye
leakage experiments on POPG vesicles as a function of
peptide concentration. Carboxyfluorescein is self-quenched
if it is incorporated into the vesicle at high (40 mM) concen-
trations. Disruption of the integrity of the membrane of the
vesicle by the peptide allows carboxyfluorescein to escape,
reducing the effective concentration and eliminating the
self-quenching effect, which can be normalized by total
disruption of the vesicles by Triton-X. Fig. 6 shows the
increase in fluorescence after the addition of PAP248-286 to
100 mM POPG vesicles. The leakage of the dye carboxy-
fluorescein from large unilamellar vesicles upon the addition
of PAP248-286 indicates that PAP248-286 induces significant
membrane disruption if it binds to the membrane. PAP248-
286 did not induce significant disruption until a certain critical
concentration (~500 nM) was reached. Membrane disruption
in POPG vesicles increases sigmoidally beyond this critical
concentration, reaching saturation at ~1.5 mM or a peptide/
lipid molar ratio of 1.5%. However, in vesicles that more
closely resemble the composition of either the viral lipid
envelope (Fig. 6 C) or the host cell (Fig. 6 B), disruption
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FIGURE 5 PAP248-286 promotes the formation of the negatively curved
inverted hexagonal (HII) phase. DSC heating scans of DiPoPE multilamellar
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2478 Brender et al.FIGURE 6 Membrane disruption caused by PAP248-286
as measured by a dye leakage assay. Dye leakage assay
as a function of PAP248-286 concentration for 100 mM
POPG vesicles (A), host-type vesicles by PAP248-286 (B),
and viral-type vesicles (C). (D) Dye leakage of the indi-
cated concentrations of POPG vesicles by 1 mMPAP248-286
as a function of NaCl concentration.of themembrane ismuch less prominent.AlthoughPAP248-286
is very effective at permeabilizing POPG vesicles at
nanomolar concentrations, even high peptide concentrations
(50 mM) are insufficient for membrane disruption when the
percentage of anionic lipids is lowered to levels that are
typical of human cells.
The ability of PAP248-286 to effectively disrupt POPG
vesicles, but not vesicles with a lower anionic lipid content,
suggests that electrostatic interactions form a large share of
the free energy of membrane binding (35,36). To further
investigate this possibility in model membrane systems, we
recorded dye leakage from 7:3 POPG/POPC vesicles as
a function of increasing salt concentration (Fig. 6 D). At
the 150 mM NaCl concentration used in previous experi-
ments, the membrane disruption induced by PAP248-286 is
negligible for this lipid system. However, when the NaCl
concentration is lowered to 100 mM NaCl, there is signifi-
cant membrane permeabilization, and the vesicles are almost
entirely disrupted at 50 mM NaCl. This result, along with
the polar and cationic nature of the peptide and the known
correspondence between basic residues and the ability of
PAP248-286 to enhance HIV activity, suggests that the bind-
ing of PAP248-286 to the membrane is primarily electrostatic
in nature. However, the binding may be modulated by other
factors, such as the degree of cholesterol incorporation into
the membrane and the phospholipid type (37).
PAP248-286 interacts weakly with the surface
of lipid bilayers
The phase transition between the gel and liquid crystalline
phases of lipids can be strongly perturbed by the binding
of peptides to the membrane depending on the binding
mode (38,39). The degree of perturbation is strongly depen-
dent on the mode of binding. An amphiphilic peptide that
partly penetrates into the interior of the membrane will inter-
fere with lipid-lipid interactions within the membrane and
therefore decrease the cooperativity of the phase transition,Biophysical Journal 97(9) 2474–2483resulting in a decrease in the sharpness of the phase transi-
tion. Peptide binding at the water/membrane interface also
disorders the surrounding lipids because the acyl chains of
the lipid molecules must reorganize to fill the void created
beneath the peptide in the hydrophobic core of the
membrane, resulting in a decrease in the DH and phase tran-
sition temperature (Tm) associated with the transition. On
the other hand, a peptide that is bound only to the surface
of the membrane and does not penetrate into the interior of
the membrane, or is bound in a transmembrane orientation
will not have a significant effect on the phase transition
because the lipid-lipid interactions are disrupted to a much
lower degree compared to a surface-associated peptide (40).
Fig. 7 A shows the effect of PAP248-286 on the phase transi-
tion of mixed 7:3 DMPC/DMPG vesicles as determined
by differential scanning calorimetry (DSC). TheDSC thermo-
gram of pure 7:3 DMPC/DMPG vesicles shows a single main
transition at 24.5C indicative of the main gel-to-liquid
crystalline phase transition, and a smaller pretransition at
5.4C indicative of the rippled gel-to-gel phase transition
(41). The addition of PAP248-286 up to 2 mol % did not have a
significant effect on the thermodynamics of the liquid
crystalline-to-gel phase transition, except for a slight
widening of the transition and a small shift of the transition
to lower temperatures when the PAP248-286 concentration
exceeded 1 mol %. A similar effect was previously reported
for low-molecular-weight polylysine. The absence of a signif-
icant effect suggests that the peptide is either peripherally
bound to the surface of the membrane or is deeply inserted
into the membrane in a transmembrane orientation, which
would require less reorganization of the lipids to accommo-
date the peptide than a surface-bound orientation would.
Although both types of binding would give rise to DSC
thermograms similar to Fig. 7 A, a deep insertion into the
membrane seems unlikely considering the high positive
charge on the peptide and the lack of a hydrophobic or even
amphipathic region in the peptide. Significantly, the main
transition peak is nearly symmetrical at all concentrations of
SEVI Promotes Lipid FusionPAP248-286, indicating that PAP248-286 does not induce
domain formation in the membrane or phase separation of
the sample, as has been observed for some rigid polycationic
compounds and high-molecular-weight polylysines at higher
mole percentages.
PAP248-286 binds to membranes in a partial
a-helical conformation
In addition to the random coil and amyloid b-sheet confor-
mations found in solution, amyloid proteins frequently
bind to membranes in a-helical conformations (42–44).
The a-helical conformation represents an intermediate state
before b-sheet aggregation and, perhaps paradoxically at
first glance, is believed to catalyze the transition from
the random coil conformation to the amyloid state (45).
The a-helical conformation has been implicated as being
responsible for the membrane-perturbing effects of many
amyloid proteins. To see whether PAP248-286 binds to lipid
membranes in an a-helical conformation, we obtained CD
spectra of PAP248-286 incubated with 7:3 POPC/POPG lipo-
somes (Fig. 7 B). The CD spectra show that freshly dissolved
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FIGURE 7 (A) Differential scanning calorimetry of the pretransition and
the main gel-to-liquid crystalline phase transition of 7:3 DMPC:DMPG vesi-
cles at the indicated PAP248-286/lipid molar ratios. (B) CD spectra of 7 mM
PAP248-286 in 10 mM sodium phosphate buffer with 150 mM NaF at
pH 7.3 as a function of incubation time after the addition of 1 mM 7:3
POPC/POPG vesicles.PAP248-286 exists primarily in a random coil conformation, in
agreement with previous findings. The addition of liposomes
induces a conformational change in the peptide to a partial
helical structure (Fig. 7 B). Analysis of the spectra shown
in Fig. 7 B by the CONTINLL program suggests a helical
content of ~30% (46); however, it is likely that this
number underestimates the true helical content of the sample,
as the signal from the peptide is apparently diminished at
higher lipid concentrations where aggregation of the lipid
vesicles is visible to the naked eye (see Fig. 3 E). An artifi-
cially low apparent concentration of PAP248-286 tends to
reduce the apparent conformational change upon lipid
binding, because the simulated spectra constructed by the
CONTINLL program compensates for the missing peptide
signal by adding a random coil component of opposite
sign. A comparison of PAP248-286 with the crystal structure
of the full PAP protein predicts two a-helices (residues
3–12 and residues 16–27) for PAP248-286 separated by a flex-
ible region containing the two glycines at positions 13 and 14
(47). Although PAP248-286 is likely to adopt a different struc-
ture when bound to the membrane, the crystal structure of the
full PAP protein does give an indication of the putative
helical regions of membrane-bound PAP248-286.
DISCUSSION
PAP248-286 causes the formation of large lipid
ﬂocculates at acidic, but not neutral, pH
Freshly dissolved PAP248-286 has a clear tendency to induce
the aggregation of liposomes at acidic pH, but not at neutral
pH, as indicated by the increase in optical density due to the
higher scattering caused by larger aggregated liposomes. At
neutral pH, none of the compounds tested, including the pol-
ycations polybrene and the amyloid peptides PAP248-286 and
human-IAPP, caused significant liposome aggregation. In
fact, at neutral pH, PAP248-286 had the least effect on lipo-
some aggregation of all the compounds tested. At an acidic
pH mirroring the vaginal environment before fertilization,
the situation was quite different: PAP248-286 and the polyca-
tionic polymer compounds caused significant aggregation at
micromolar concentrations in partially anionic 7:3 POPC/
POPG membranes and host-type membranes, and also in
viral-type membranes to a somewhat smaller degree. Signif-
icantly, freshly dissolved human-IAPP, a strongly amyloido-
genic peptide with a relatively high positive charge, did not
strongly affect lipid aggregation. Furthermore, the lipid
aggregates formed in this process were very large and rapidly
fell out of solution and sedimented to the bottom.
The ability of PAP248-286 to induce the formation of large
lipid flocculates at acidic pH has interesting consequences if
this result is confirmed in vivo. First, the presence of lipid
aggregates confirms that PAP248-286 interacts with model
membranes, and, more importantly, has the ability to interact
with two membranes simultaneously. Bridging interactions
2479Biophysical Journal 97(9) 2474–2483
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meric or small oligomeric species of PAP248-286 can enhance
infection by enhancing viral binding to the cell. Second, the
formation of large lipid aggregates may alter the mechanism
of the initial approach of the virus to the cell surface.
Detailed mechanistic studies have shown that the entry of
retroviruses is ultimately limited by the diffusion of the virus
to the target cell surface (48,49). Given enough time, all
retrovirus particles will reach the appropriate receptor neces-
sary to trigger fusion of the retrovirus with the target cell
through Brownian motion. However, retroviruses are
unstable in solution and have short half-lives (estimated to
be on the order of ~6 h for free virions of HIV) that limit
the available window of opportunity for infection (50).
Brownian motion of the relatively small viral particle is
inherently random and slow, and thus most virions are
unable to reach the target cell surface before being destroyed.
If viral particles aggregate together, the inefficient diffusion-
limited capture process may be bypassed in favor of much
more rapid sedimentation of the virus to the cell surface by
convective processes (17). This process has been shown to
be effective in promoting retrovirus infection in vitro, where
directed mass transfer of the virus to plated cells significantly
enhances infection rates (11,17,51–53). The effect of virus
aggregation in the in vivo situation, where cell densities
are much higher and target cells are in a three-dimensional
matrix, is much less certain; however, the influence of
PAP248-286/SEVI on virus aggregation and convective trans-
port warrants further investigation (54,55).
PAP248-286 is fusiogenic and alters the physical
properties of the membrane in a way that may
favor fusion by gp41
In contrast to the formation of lipid flocculates, which can
only be detected at acidic pH, PAP248-286 causes lipid mixing
at both neutral and acidic pH in the absence of calcium. Lipid
mixing is one of the prerequisites for proper fusion of two
membranes. In this instance, PAP248-286 is more effective
than polybrene but less effective than polylysine at both of
the pH values tested. In addition to the direct promotion of
fusion by PAP248-286, binding of PAP248-286 to the cell
membrane changes the physical properties of the membrane
in a way that may make it more susceptible to fusion by the
gp41 protein of the HIV virus. Specifically, PAP248-286
induces negative curvature in the membrane and disrupts
lipid-lipid contacts, thus reducing the force needed by the
HIV gp41 protein to rupture the membrane and promote
fusion (56). Lastly, we have shown that PAP248-286 can affect
the membrane strongly enough to disrupt membrane integ-
rity to allow the passage of small molecules (Fig. 6). This
is an indication of a general weakening of the membrane
structure induced by PAP248-286. There is also an indication
that such additions of additives that alter membrane structure
may have such an effect on viral fusion. Pretreatment ofBiophysical Journal 97(9) 2474–2483cultured cells with phosphatidylserine, a fusion-promoting
lipid, results in a relatively large increase (2- to 20-fold) in
enveloped virus infection rates that is cumulative with the
charge-shielding effect of polybrene (57). This effect has
been linked to facilitation of the viral fusion process, because
it occurs without a concomitant increase in viral binding to
cells or virus receptor levels (57).
Role of a helical conformation of PAP248-286 in
lipid-bridging interactions
The CD spectra of PAP248-286 bound to POPC/POPG vesi-
cles suggest that PAP248-286 binds initially to the membrane
in a partial helical conformation, and that it can be stabilized
at low concentration in this conformation for extended
periods of time. This finding puts PAP248-286 in the class
of amyloid proteins that are essentially unstructured in solu-
tion but adopt a-helical conformations when initially bound
to membranes (58,59). As helical conformations are also
common early intermediates in the fibrillogenesis of amyloi-
dogenic peptides, the binding of PAP248-286 to the cellular
membrane may be important for catalyzing the formation
of SEVI from monomeric PAP248-286. (45,60) Although at
first glance it might seem paradoxical that the stabilization
of helical states of PAP248-286 would promote the formation
of an entirely different fold, the self-association of helical
stretches in PAP248-28 can catalyze the amyloid formation
by increasing the effective concentration of unfolded and
aggregation-prone sequences within PAP248-286 through the
reduction of translational and rotational diffusion. This tem-
plating effect is partially responsible for the acceleration of
fibrillogenesis of many amyloidogenic proteins by lipid
membranes, helix-promoting solvents, and molecular crowd-
ing agents. Although the partially helical structure detected
here was found to be stable only when bound to membranes,
it may also represent a transient conformation of the peptide
in solution. The CD spectra of PAP248-286 in solution suggest
a structure that is almost entirely in a random coil conforma-
tion; however, NMR studies have shown that other amyloi-
dogenic peptides that appear unstructured by CD and FTIR
transiently adopt helical structure (61,62).
A partially helical conformation of PAP248-286 may also
explain the fusiogenic activity of the peptide. In this a-helical
conformation, the PAP248-286 peptide can be expected to bind
parallel to the surface of the bilayer, since a transmembrane
orientation of the peptide is unlikely due to the difficulty
in this orientation of simultaneously shielding all of the
positively charged residues that radiate from the helix in all
directions (see Fig. 8). A surface-associated helical conforma-
tion of PAP248-286 has several features that make it an attrac-
tive model to explain the bilayer fusion induced by the
monomeric form of the peptide. First, electrostatic binding
of the peptide to the surface is likely to partially dehydrate
the lipid headgroup, removing a steric barrier to fusion in
amanner similar to that caused by the binding of polyethylene
SEVI Promotes Lipid Fusion 2481glycol (63). The removal of water from the lipid headgroup
also has the effect of reducing the effective headgroup size
of the lipid relative to the acyl chain. To compensate for this
mismatch in relative sizes between the two regions of the lipid
molecule, the membrane can curve outward, which is an obli-
gate step for fusion that is strongly energetically unfavorable
in the absence of PAP248-286. Second, some of the lysine resi-
dues in this model face into the membrane, where they would
interact with the lipid headgroups of the membrane, whereas
other lysine residues face in the opposite direction into the
aqueous phase. In this position, they are optimally positioned
to diminish the long-range Coulombic repulsion that occurs
when two bilayers of like sign are brought into contact.
Furthermore, as the two bilayers approach each other during
the initial stages of fusion, it is likely that the lysine chains
of PAP248-286 reach into the second bilayer to serve as an
anchor linking the two bilayers together.
Since the structure of the amyloid form of PAP248-286 is not
known, it is difficult to make predictions about the possible
membrane interactions of the amyloid form of PAP248-286 as
they are likely to be highly dependent on the supramolecular
organization of the peptide. Notably, other amyloid proteins,
which share the same gross cross-b sheet structure as the
amyloid form of PAP248-286, are less effective at promoting
HIV infectivity (4). The determination of the high-resolution
structure of the amyloid form of PAP248-286 will likely be very
informative in illuminating the nature of these differences.
CONCLUSIONS
Freshly prepared PAP248-286 that is initially in the random
coil conformation interacts strongly with lipid membranes,
FIGURE 8 Two views of the proposed a-helical form of PAP248-286
showing the radial distribution of positively charged residues and the
possible interaction with the membrane. The secondary structure of
PAP248-286 within full-length PAP. The letter ‘‘C’’ represents a residue in
the random coil conformation, ‘‘H’’ is a residue in a helical conformation,
and ‘‘E’’ is a residue in the b-sheet conformation.adopting a partial helical conformation that appears to
promote bridging interactions between membranes and their
eventual fusion by screening unfavorable electrostatic inter-
actions. In this state, PAP248-286 induces alterations in a
variety of model membranes that appear to weaken lipid-
lipid interactions and promote curved lipid phases that would
be conducive to fusion. These alterations in membrane struc-
ture are not specific for the amyloid form of PAP248-286 and
are similar to changes in membrane structure produced by
other disordered, polycationic polymers that also promote
retroviral infection. The relative importance of the partially
helical conformation for SEVI enhancement of HIV infec-
tion warrants further investigation. Given the very high
degree of enhancement of HIV infectivity induced by
SEVI, and its ubiquity in seminal fluid, such research is
likely to have a high impact on investigations regarding
HIV transmission and prevention.
SUPPORTING MATERIAL
Materials and methods are available at http://www.biophysj.org/biophysj/
supplemental/S0006-3495(09)01394-0.
This study was supported by research funds from the National Institutes of
Health (to A.R.).
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